ADNI
In a recent study, the 48-protein panel improved the diagnostic performance of existing Alzheimer's markers and helped predict progression of the disease.
Caprion Launches MRM-MS-based CNS Assay as Part of Push into Protein Discovery Panel Business
Premium
NEW YORK (GenomeWeb) – Proteomics firm Caprion this week launched its CNS ProteoCarta panel for the study of central nervous system diseases.
GWAS Unearths Variants with Ties to Alzheimer's Biomarker
NEW YORK (GenomeWeb News) – Common genetic variants at three newly detected loci appear to be linked to elevated Alzheimer's disease risk, according to a study out today in the journal Neuron.
Study Suggests Flaws in Standard Cognitive Alzheimer's Test Could Undermine Drug, Biomarker Research
Premium
According to a team led by researchers at Plymouth University, there are significant flaws in the standard cognitive test used to diagnose and evaluate Alzheimer's disease patients, which could be hampering efforts to develop treatments and biomarkers for the disease.
A consortium of researchers working as part of the Alzheimer's Disease Neuroimaging Initiative has completed an analysis of potential plasma protein biomarkers for Alzheimer's in three separate patient cohorts, identifying four analytes associated with the disease.
Apr 22, 2011
Jan 7, 2011
Oct 15, 2010